Nelarabine 5 mg/mL
Nelarabine · INJECTION · Zydus Lifesciences Limited
Nelarabine is a injection containing nelarabine at 5 mg/mL, taken intravenous. Manufactured by Zydus Lifesciences Limited.
Key Facts
- Brand Name
- Nelarabine
- Generic Name
- Nelarabine
- NDC Code (Product)
70771-1685- Manufacturer
- Zydus Lifesciences Limited
- Strength
- 5 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA215037
- Drug Class
- Nucleoside Metabolic Inhibitor [EPC]
- Marketing Start
- 11/17/2021
Recall History
Zydus Pharmaceuticals (USA) Inc
Failed Impurities/Degradation Specifications
GlaxoSmithKline, LLC.
Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.
Zydus Pharmaceuticals (USA) Inc
Failed Impurities/Degradation Specifications
Frequently Asked Questions
What is Nelarabine used for?
Nelarabine contains Nelarabine. It is a injection taken intravenous. Consult your doctor for specific uses.
Is Nelarabine a controlled substance?
Nelarabine is not classified as a controlled substance by the DEA.
What is the generic name for Nelarabine?
The generic name for Nelarabine is Nelarabine. There are 5 other brand versions of Nelarabine.
What is the NDC code for Nelarabine 5 mg/mL?
The NDC (National Drug Code) for Nelarabine 5 mg/mL is 70771-1685, listed by Zydus Lifesciences Limited.